Madrigal Pharmaceuticals Inc (MDGL)
312.00 x 3 333.00 x 2
Pre-market by (Cboe BZX)
326.79 +6.86 (+2.14%) 04/25/25 [NASDAQ]
312.00 x 3 333.00 x 2
Pre-market 326.79 unch (unch) 16:00 ET
for Fri, Apr 25th, 2025
Results
download Want to compare other data? Select Fields| Symbol | MDGL | CORT | STVN | ||
| Company | Madrigal Pharmaceuticals Inc | Corcept Therapeutics | Stevanato Group S.P.A. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 315.76 | 72.00 | 21.74 | ||
| High | 329.58 | 72.00 | 21.80 | ||
| Low | 313.52 | 72.00 | 21.14 | ||
| Last | 326.79 | 72.00 | 21.59 | ||
| Change | +6.86 | +0.29 | -0.30 | ||
| % Change | +2.14% | +0.40% | -1.37% | ||
| Volume | 397,300 | 722 | 218,200 | ||
| 20-Day Average Volume | 352,725 | 2,606,231 | 326,540 | ||
| Previous Close | 319.93 | 71.71 | 21.89 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 315.85 | 73.72 | 21.00 | ||
| 20-Day Raw Stochastic | 76.99% | 18.44% | 76.46% | ||
| 20-Day Relative Strength | 51.81% | 53.57% | 52.52% | ||
| Weighted Alpha | +24.61 | +122.48 | -13.31 | ||
| Today's Opinion | 40% Buy | 88% Buy | 72% Buy | ||
| Previous Opinion | 24% Buy | 88% Buy | 72% Buy | ||
| Last Month's Opinion | 88% Buy | 8% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.33% since 04/17/25 | +14.47% since 04/21/25 | -1.24% since 04/17/25 | ||
| Low | 276.20 on 04/21/25 | 62.04 on 04/22/25 | 21.13 on 04/22/25 | ||
| High | 329.58 on 04/25/25 | 76.17 on 04/24/25 | 22.46 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | -4.81% since 03/25/25 | +31.80% since 03/28/25 | +2.27% since 03/25/25 | ||
| Low | 276.20 on 04/21/25 | 61.75 on 04/21/25 | 18.18 on 04/09/25 | ||
| High | 343.41 on 03/26/25 | 117.33 on 03/31/25 | 22.64 on 04/15/25 | ||
| 3-Month | |||||
| %Chg | -0.41% since 01/24/25 | +18.69% since 01/28/25 | +0.23% since 01/24/25 | ||
| Low | 276.20 on 04/21/25 | 52.45 on 03/07/25 | 17.81 on 03/03/25 | ||
| High | 377.46 on 02/26/25 | 117.33 on 03/31/25 | 23.00 on 03/24/25 | ||
| 6-Month | |||||
| %Chg | +55.12% since 10/25/24 | +48.94% since 10/28/24 | +25.01% since 10/25/24 | ||
| Low | 210.32 on 10/28/24 | 42.01 on 10/31/24 | 17.23 on 10/28/24 | ||
| High | 377.46 on 02/26/25 | 117.33 on 03/31/25 | 24.90 on 12/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,941,729 | 7,854,698 | 5,760,074 | ||
| Shares Outstanding, K | 22,080 | 105,503 | 302,843 | ||
| Annual Sales | 180,130,000 | 675,040,000 | 1,194,680,000 | ||
| Annual Net Income | -465,890,000 | 141,210,000 | 127,450,000 | ||
| Last Quarter Sales | 103,320,000 | 181,890,000 | 353,380,000 | ||
| Last Quarter Net Income | -59,420,000 | 30,750,000 | 51,800,000 | ||
| 60-Month Beta | -0.69 | 0.15 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.71 on 02/26/25 | 0.26 on 02/26/25 | 0.20 on 03/06/25 | ||
| Latest Earnings Date | 05/01/25 | 05/07/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 57.83 | 41.52 | ||